ADIPOQ and diabetes mellitus: In older human patients with AD, elevated adiponectin has been reported to be positively correlated with CSF amyloid levels82, and the “adiponectin paradox” describes elevated adiponectin in end-stage diseases, including diabetes, cardiovascular disease, and AD83–86.